Internal Medicine, Pulmonary Disease · Beaumont, TX
NPI
1720283336
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3480 College St
Beaumont, TX, 77701
Phone (409) 813-1677
Groups this clinician bills Medicare through
Medicare paid, 2024
$134K
6,904 services
Medicare patients, 2024
733
Average age 75
Drug cost, 2024
$4.5M
6,594 prescriptions
Company payments, 2025
$224K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Juan B Iribarren was code J1010 (injection, methylprednisolone acetate, 1 mg), 2,081 times for 25 patients. In total Juan B Iribarren billed 6,904 services in 48 codes, and Medicare paid $134K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,081 | 25 | $0.10 | $210 |
| 95165 Treatment - Miscellaneous | Office | 1,005 | 27 | $10.28 | $10K |
| 95004 Test - Miscellaneous | Office | 980 | 14 | $2.42 | $2,369 |
| 99232 Hospital E&M - Subsequent | Facility | 559 | 201 | $61.44 | $34K |
| 99214 Office E&M - Established | Office | 355 | 240 | $94.40 | $34K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 277 | 35 | $0.09 | $24.96 |
| 99231 Hospital E&M - Subsequent | Facility | 234 | 141 | $38.62 | $9,037 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 152 | 34 | $0.36 | $54.82 |
| 95117 Treatment - Miscellaneous | Office | 131 | 19 | $8.79 | $1,151 |
| 71046 X-ray - Chest | Office | 103 | 100 | $16.31 | $1,680 |
| 99204 Office E&M - New | Office | 101 | 101 | $123.63 | $12K |
| 94664 E&M - Miscellaneous | Office | 99 | 94 | $13.10 | $1,297 |
| 94729 Pulmonary Function Testing | Facility | 98 | 98 | $6.88 | $674 |
| 94726 Pulmonary Function Testing | Facility | 94 | 94 | $9.27 | $871 |
| 94010 Pulmonary Function Testing | Facility | 83 | 83 | $6.26 | $519 |
By year: 2022 $167K for 5,042 services; 2023 $172K for 5,511 services; 2024 $134K for 6,904 services.
Medicare prescription drug claims, 2024
In 2024, the drug Juan B Iribarren prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,581 prescriptions and refills. In total Juan B Iribarren wrote 6,594 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,581 | 1,894 | 392 | $1.2M |
| Montelukast Sodium Generic | 1,078 | 1,901 | 306 | $9,010 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 592 | 659 | 242 | $20K |
| Zafirlukast Generic | 542 | 792 | 140 | $42K |
| Azithromycin Generic | 403 | 554 | 260 | $7,523 |
| Dupixent Pen Dupilumab | 356 | 393 | 53 | $1.5M |
| Prednisone Generic | 338 | 373 | 244 | $1,030 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 306 | 346 | 95 | $209K |
| Breo Ellipta Fluticasone/Vilanterol | 167 | 215 | 44 | $82K |
| Fluticasone Propionate Generic | 113 | 190 | 33 | $1,264 |
| Ventolin Hfa Albuterol Sulfate | 90 | 104 | 43 | $5,425 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 65 | 72 | 19 | $7,892 |
| Levofloxacin Generic | 61 | 61 | 52 | $337 |
| Spiriva Respimat Tiotropium Bromide | 54 | 67 | 11 | $34K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 53 | 63 | 11 | $29K |
Brand drugs: 3,403 claims; generic drugs: 3,133 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Juan B Iribarren $224K ($224K in general payments such as food, travel and fees) from 15 companies. The largest payer was Genzyme Corporation with $107K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 77 | $107K |
| AstraZeneca Pharmaceuticals LP AZN | 96 | $99K |
| Regeneron Healthcare Solutions, Inc. REGN | 22 | $17K |
| Insmed, Inc. INSM | 23 | $324 |
| GlaxoSmithKline, LLC. GSK | 20 | $164 |
| Inspire Medical Systems, Inc. INSP | 3 | $106 |
| Baxter Healthcare BAX | 3 | $64.35 |
| Viatris Specialty LLC | 3 | $63.56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57.36 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $45.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.